tefinostat (CHR-2845) / Chroma Therap 
Welcome,         Profile    Billing    Logout  

1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tefinostat (CHR-2845) / Chroma Therap
2015-002281-23: A clinical trial to test the safety and effectiveness of a new drug, tefinostat, for patients with chronic myelomonocytic leukaemia

Ongoing
2
40
Europe
Tefinostat, CHR-2845, Capsule
Cardiff University
Chronic myelomonocytic leukaemia (CMML), CMML is a form of leukaemia characterised by high numbers of white blood cells called monocytes in the blood and bone marrow., Diseases [C] - Cancer [C04]
 
 

Download Options